Ozempic Weight Loss Warnings for Teens — Not a Magic Shot
Ozempic is being prescribed to teens and now the medication shortage has gotten worse since I first wrote about it in January. Now almost 6 months later, new American childhood obesity reports are recommending more medications like Ozempic and even surgery to prevent diabetic complications.
However, parents should be informed about the side effects and harmful trends surrounding this new Ozempic craze. According to Yasmin Tayag’s article in the Atlantic:
Somehow, America’s desire for Ozempic is only growing. The drug’s active ingredient, semaglutide, is sold as an obesity medication under the brand name Wegovy — and it has become so popular that its manufacturer, Novo Nordisk, recently limited shipments to the U.S. and paused advertising to prevent shortages. Its promise has enticed would-be patients and set off a pharmaceutical arms race to create more potent drugs.
Part of the interest stems from Ozempic’s potential in teens: In December, the FDA approved Wegovy as a treatment for teenagers with obesity, which affects 22 percent of 12-to-19-year-olds in the United States. The drug’s ability to spur weight loss in adolescents has been described as “mind-blowing.” In January, in its new…
